Drug · DIN 02041510
DAPSONE
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since July 10, 2024; first marketed December 31, 1994.
- Drug Identification Number (DIN)
- 02041510
- Company (DIN owner)
- Everest Life Sciences LlcMonroe, New Jersey, United States
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Dapsone J04BA02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DAPSONE | 100 MG |